Newton-Bishop J - Search Results

1

Total serum N-glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma.

Visconti A, Rossi N, Deriš H, Lee KA, Hanić M, Trbojević-Akmačić I, Thomas AM, Bolte LA, Björk JR, Hooiveld-Noeken JS, Board R, Harland M, Newton-Bishop J, Harries M, Sacco JJ, Lorigan P, Shaw HM, de Vries EGE, Fehrmann RSN, Weersma RK, Spector TD, Nathan P, Hospers GAP, Sasieni P, Bataille V, Lauc G, Falchi M. Visconti A, et al. Among authors: newton bishop j. BMC Cancer. 2023 Feb 18;23(1):166. doi: 10.1186/s12885-023-10511-3. BMC Cancer. 2023. PMID: 36805683 Free PMC article.

2

Family studies in melanoma: identification of the atypical mole syndrome (AMS) phenotype.

Newton Bishop JA, Bataille V, Pinney E, Bishop DT. Newton Bishop JA, et al. Melanoma Res. 1994 Aug;4(4):199-206. doi: 10.1097/00008390-199408000-00001. Melanoma Res. 1994. PMID: 7950355

3

The association between naevi and melanoma in populations with different levels of sun exposure: a joint case-control study of melanoma in the UK and Australia.

Bataille V, Grulich A, Sasieni P, Swerdlow A, Newton Bishop J, McCarthy W, Hersey P, Cuzick J. Bataille V, et al. Br J Cancer. 1998;77(3):505-10. doi: 10.1038/bjc.1998.81. Br J Cancer. 1998. PMID: 9472652 Free PMC article.

4

Solar keratoses: a risk factor for melanoma but negative association with melanocytic naevi.

Bataille V, Sasieni P, Grulich A, Swerdlow A, McCarthy W, Hersey P, Newton Bishop JA, Cuzick J. Bataille V, et al. Int J Cancer. 1998 Sep 25;78(1):8-12. doi: 10.1002/(sici)1097-0215(19980925)78:1<8::aid-ijc2>3.0.co;2-u. Int J Cancer. 1998. PMID: 9724086 Free article.

5

The genetics of melanoma: the UK experience.

Newton Bishop JA, Harland M, Bishop DT. Newton Bishop JA, et al. Clin Exp Dermatol. 1998 Jul;23(4):158-61. doi: 10.1046/j.1365-2230.1998.00344.x. Clin Exp Dermatol. 1998. PMID: 9894359 Review.

6

Mutation testing in melanoma families: INK4A, CDK4 and INK4D.

Newton Bishop JA, Harland M, Bennett DC, Bataille V, Goldstein AM, Tucker MA, Ponder BA, Cuzick J, Selby P, Bishop DT. Newton Bishop JA, et al. Br J Cancer. 1999 Apr;80(1-2):295-300. doi: 10.1038/sj.bjc.6690354. Br J Cancer. 1999. PMID: 10390011 Free PMC article.

7

Mutation screening of the CDKN2A promoter in melanoma families.

Harland M, Holland EA, Ghiorzo P, Mantelli M, Bianchi-Scarrà G, Goldstein AM, Tucker MA, Ponder BA, Mann GJ, Bishop DT, Newton Bishop J. Harland M, et al. Genes Chromosomes Cancer. 2000 May;28(1):45-57. Genes Chromosomes Cancer. 2000. PMID: 10738302

8

An assessment of the CDKN2A variant Ala148Thr as a nevus/melanoma susceptibility allele.

Bertram CG, Gaut RM, Barrett JH, Pinney E, Whitaker L, Turner F, Bataille V, Dos Santos Silva I, J Swerdlow A, Bishop DT, Newton Bishop JA. Bertram CG, et al. J Invest Dermatol. 2002 Oct;119(4):961-5. doi: 10.1046/j.1523-1747.2002.01825.x. J Invest Dermatol. 2002. PMID: 12406345 Free article.

9

Exposure to the sun and sunbeds and the risk of cutaneous melanoma in the UK: a case-control study.

Bataille V, Winnett A, Sasieni P, Newton Bishop JA, Cuzick J. Bataille V, et al. Eur J Cancer. 2004 Feb;40(3):429-35. doi: 10.1016/j.ejca.2003.09.030. Eur J Cancer. 2004. PMID: 14746862

10

An assessment of a variant of the DNA repair gene XRCC3 as a possible nevus or melanoma susceptibility genotype.

Bertram CG, Gaut RM, Barrett JH, Randerson-Moor J, Whitaker L, Turner F, Bataille V, dos Santos Silva I, Swerdlow AJ, Bishop DT, Newton Bishop JA. Bertram CG, et al. J Invest Dermatol. 2004 Feb;122(2):429-32. doi: 10.1046/j.0022-202X.2003.12541.x. J Invest Dermatol. 2004. PMID: 15009726 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

216 results

Search Page